Genprex Stock Alpha and Beta Analysis
| GNPX Stock | USD 1.14 0.04 3.64% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Genprex. It also helps investors analyze the systematic and unsystematic risks associated with investing in Genprex over a specified time horizon. Remember, high Genprex's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Genprex's market risk premium analysis include:
Beta (7.68) | Alpha 5.03 | Risk 39.74 | Sharpe Ratio 0.11 | Expected Return 4.43 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Genprex |
Genprex Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Genprex market risk premium is the additional return an investor will receive from holding Genprex long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Genprex. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Genprex's performance over market.| α | 5.03 | β | -7.68 |
Genprex expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Genprex's Buy-and-hold return. Our buy-and-hold chart shows how Genprex performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Genprex Market Price Analysis
Market price analysis indicators help investors to evaluate how Genprex stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Genprex shares will generate the highest return on investment. By understating and applying Genprex stock market price indicators, traders can identify Genprex position entry and exit signals to maximize returns.
Genprex Return and Market Media
The median price of Genprex for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 is 0.67 with a coefficient of variation of 80.38. The daily time series for the period is distributed with a sample standard deviation of 0.78, arithmetic mean of 0.97, and mean deviation of 0.66. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1 and Type-2 Diabetes | 09/04/2024 |
2 | Genprex Featured in CEOCFO Magazine Discussing Novel Gene Therapies for Cancer and Diabetes | 09/23/2024 |
3 | Genprex Collaborators to Present Positive Preclinical Data on Reqorsa Gene Therapy at the Society for Immunotherapy of Cancer 2024 Annual Meeting | 10/07/2024 |
4 | Why Stride Shares Are Trading Higher By Over 24 Here Are 20 Stocks Moving Premarket | 10/23/2024 |
5 | Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa Gene Therapy for the Treatment of Lung Cancer, Mesothelioma and Glioblastoma | 10/28/2024 |
6 | Genprex Signs Exclusive License to Additional Gene Therapy Technologies with the University of Michigan for the Treatment of Lung Cancer | 11/20/2024 |
About Genprex Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Genprex or other stocks. Alpha measures the amount that position in Genprex has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2024 (projected) | PB Ratio | 1.49 | 3.12 | 1.61 | Capex To Depreciation | 3.72 | 2.34 | 4.52 |
Genprex Upcoming Company Events
As portrayed in its financial statements, the presentation of Genprex's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Genprex's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Genprex's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Genprex. Please utilize our Beneish M Score to check the likelihood of Genprex's management manipulating its earnings.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 27th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Genprex
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Genprex Stock Analysis
When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.